IIM
ALDX icon

Ironwood Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History

Ironwood Investment Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,424
Closed -$214K – 181
2021
Q3 		$214K Hold
24,424
– – 0.11% 162
2021
Q2 		$277K Hold
24,424
– – 0.14% 154
2021
Q1 		$290K Buy
+24,424
New +$281K 0.15% 147
2019
Q2 		– Sell
-12,836
Closed -$116K – 151
2019
Q1 		$116K Buy
+12,836
New +$109K 0.09% 149

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Ironwood Investment Management's ALDX Position: Q4 2021 in Review

Ironwood Investment Management sold out of Aldeyra Therapeutics (ALDX) in Q4 2021, closing a stake of 24,424 shares — an estimated $214K sold.

Ironwood Investment Management first reported a position in ALDX in Q1 2019 and held it in 4 quarters. The position peaked at $290K in Q1 2021. 115 funds tracked by Wall St. Rank hold ALDX as of Q4 2021.

  • Ironwood Investment Management reported no remaining Aldeyra Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Ironwood Investment Management sold 24,424 Aldeyra Therapeutics shares in Q4 2021, an estimated $214K.
  • Ironwood Investment Management first reported a position in Aldeyra Therapeutics in Q1 2019 and held it in 4 quarters.
  • Ironwood Investment Management's Aldeyra Therapeutics position peaked at $290K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2021.

Based on Ironwood Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.